Medical Technology Innovation

Meddent Innovative Concepts

Transforming the Future of Medical, Dental, Orthopedic and Veterinary Innovation

A portfolio-driven innovation platform

Meddent Innovative Concepts is a medical technology innovation company focused on the development, patenting, licensing, and commercialization of next-generation medical devices, surgical instruments, biomaterials, and biotechnology solutions serving the orthopedic, dental, and veterinary healthcare markets.

Our mission is to improve clinical outcomes, increase procedural efficiency, and enhance patient care through innovative technologies that address unmet needs faced by healthcare professionals worldwide.

Operating as a portfolio-driven innovation platform, Meddent Innovative Concepts develops proprietary intellectual property and strategically advances products from concept through commercialization, creating multiple pathways for revenue generation including licensing agreements, royalty streams, strategic partnerships, acquisitions, and direct product sales.

Large and Growing Global Markets

The global markets served by Meddent Innovative Concepts represent hundreds of billions of dollars in annual healthcare spending:

  • Orthopedic Devices
  • Implant Dentistry
  • Surgical Instrumentation
  • Regenerative Medicine
  • Biomaterials
  • Veterinary Medicine
  • Veterinary Dentistry

Rapid advances in technology, aging populations, increasing demand for minimally invasive procedures, and the global expansion of healthcare access continue to drive growth across these sectors.

Our strategy is to identify underserved clinical challenges and develop proprietary solutions capable of becoming new standards of care.

Innovation-Driven Business Model

Unlike traditional manufacturers, Meddent Innovative Concepts focuses on creating high-value intellectual property assets and innovative technologies.

Our business model includes:

Intellectual Property Development

  • Patent generation and protection
  • Proprietary product platforms
  • Novel surgical technologies
  • Biomaterial innovations
  • Advanced medical device concepts

Licensing and Royalty Revenue

  • Licensing patented technologies to major medical device manufacturers
  • Royalty-based agreements
  • Co-development partnerships
  • Strategic commercialization alliances

Product Commercialization

  • Direct product development
  • Regulatory pathway management
  • Manufacturing partnerships
  • Market launch support

This diversified model provides multiple opportunities for value creation while minimizing capital-intensive manufacturing requirements.

Product Development Platform

Our development process integrates:

  • Clinical research
  • Human-centered design
  • Biomedical engineering
  • Mechanical engineering
  • Digital modeling
  • Pre-clinical testing
  • Regulatory strategy

Every product is designed around a patient-centered philosophy while maintaining commercial viability and scalability.

The company continuously evaluates opportunities across:

  • Surgical instruments
  • Dental implants
  • Components of dental implants
  • Orthopedic devices
  • Regenerative biomaterials
  • Veterinary technologies
  • Digital healthcare solutions

Clinician-Led Innovation

Products are conceived and developed by healthcare professionals who understand real-world clinical challenges.

Our multidisciplinary team includes:

  • Orthopedic Surgeons
  • Dentists
  • Veterinarians
  • Biomedical Engineers
  • Mechanical Engineers
  • Researchers
  • Product Designers

This unique combination enables us to create practical solutions with strong market adoption potential.

Portfolio

Our growing portfolio of innovative concepts, patents, and proprietary technologies creates barriers to entry and establishes long-term strategic value.

International Research Collaborations

Meddent Innovative Concepts collaborates with respected academic institutions and research organizations, including:

  • Siena University Dental SchoolItaly
  • Goethe University Dental SchoolGermany
  • De La Salle Bajio University Dental SchoolMexico

These collaborations support clinical validation, scientific advancement, and technology development.

Investment Opportunity

Meddent Innovative Concepts offers investors access to a growing portfolio of proprietary healthcare technologies targeting multiple high-growth medical sectors.

Investment capital will support:

  • Patent expansion
  • Product development
  • Regulatory activities
  • Clinical validation
  • Strategic partnerships
  • Commercialization initiatives

Our objective is to build a globally recognized medical technology company generating long-term value through intellectual property ownership, licensing revenues, and successful product commercialization.

The people behind the patents

Portrait of Dr. Igor Roshkovan, founder of Meddent Innovative Concepts, in a laboratory.

Founder & Investor — Meddent Innovative Concepts

Dr. Igor Roshkovan

DDS, MSc, MSc, PhD(c), CEO

Dr. Igor Roshkovan is the founder and investor of Meddent Innovative Concepts Company and the owner of an implantology and restorative dentistry clinic in Los Angeles, California.

His work is focused on building innovative, scalable medical solutions that integrate clinical excellence, scientific research, and technology commercialization.

His professional background is shaped by international education and extensive clinical experience across leading academic and medical institutions in Europe, the Middle East, and the USA. He holds Doctor of Dental Surgery (DDS) degrees from several universities around the world, as well as a dual degree in Master of Science (MSc) in Oral Implantology and Prosthodontics Science.

Additionally, he has obtained a PhD degree with advanced expertise in regenerative medicine, bone reconstruction, precision implantology, and modern prosthetic technologies.

Dr. Roshkovan’s core areas of specialization include guided bone regeneration (GBR), sinus augmentation, regenerative and aesthetic periodontal surgery, peri-implant disease management, and soft-tissue reconstruction.

These competencies form the foundation of both the clinical protocols and the product development strategy at Meddent Innovative Concepts.

As a technology entrepreneur and investor, he holds multiple patents and registered trademarks in the United States and Europe and is actively involved throughout the full product lifecycle—from concept and clinical validation to scaling and commercialization. His mission is to create clinically proven, IP-driven medical technologies that improve patient outcomes and generate long-term value for the global healthcare market.

Portrait of Paul Plachinda.

Co-Founder

Paul Plachinda

MS, PhD

Executive Biography

Dr. Paul Plachinda is a technology executive, systems architect, and innovator with extensive experience in advanced engineering and product development. As Co-Founder of Meddent Innovative Concepts, he plays a central role in leading several innovative projects focused on the development of next-generation medical devices. His work is dedicated to translating cutting-edge technologies into practical, scalable solutions that improve patient outcomes and advance clinical capabilities.

In his role at Meddent, Dr. Plachinda drives the design and implementation of complex medical systems, integrating advanced modeling, artificial intelligence, and digital engineering methodologies to accelerate development cycles and enhance device performance. He leads multidisciplinary teams in the creation of novel medical technologies, ensuring that innovation is aligned with regulatory requirements, safety standards, and real-world clinical needs.

With more than a decade of experience in complex systems engineering, Dr. Plachinda brings deep expertise in systems architecture, digital engineering, artificial intelligence, and advanced modeling technologies. His background includes developing digital twin platforms and intelligent control systems, which he now applies to the design and optimization of medical devices, enabling predictive performance, improved reliability, and data-driven decision-making.

As a recognized technical leader, Dr. Plachinda has contributed to numerous research and engineering initiatives, producing patents, scientific publications, and industry-recognized innovations. His ability to integrate physics-based modeling with machine learning and advanced computational methods positions him at the forefront of medical device innovation.

Dr. Plachinda’s leadership at Meddent Innovative Concepts is instrumental in advancing a portfolio of transformative medical technologies, creating long-term value for patients, healthcare providers, and strategic partners.

Areas of Expertise

  • Medical Device Development and Innovation
  • Systems Architecture and Complex Systems Engineering
  • Digital Engineering and Model-Based Systems Engineering (MBSE)
  • Artificial Intelligence and Machine Learning Applications
  • Digital Twin Development and Simulation Technologies
  • Physics-Based Modeling and Advanced Computational Methods
  • Technology Innovation and Research

Education

Doctor of Philosophy (PhD), Applied Physics
Portland State University

Master of Science (MS), Physics
Humboldt University of Berlin

Board of Advisors

Portrait of Prof. Dr. Marco Ferrari.

Leading Science Advisor

Prof. Dr. Marco Ferrari

MD, DMD, PhD

Professor Marco Ferrari, Doctor of Medicine and Dental Sciences, is a leading scientific consultant with a unique global expertise in dentistry.

Role in the Company

Scientific support for developing innovative dental and medical products and devices.

He is currently the Dean of the Faculty of Dentistry at the University of Siena, Italy, and heads the Department of Prosthodontics.

Through his interdisciplinary approach, Prof. Ferrari has built a powerful academic center that integrates cutting-edge research, clinical practice, and education. Dr. Ferrari is a bridge between science and innovation: he earned degrees from leading European and American universities and collaborates with top institutions in the UK, the US, China, and Serbia.

His over 350 scientific publications affirm his status as one of the most influential experts in the field.

As a strategic advisor, he actively supports startups in dental and medical devices, providing innovative solutions that shape the future of the industry.

Portrait of Prof. Dr. Bárbara Loureiro.

Preclinical Research & Animal Studies Lead.

Prof. Dr. Bárbara Loureiro

MV, MSc, PhD

Role in the Company

Prof. Loureiro leads scientific design, oversight, and validation of animal studies and preclinical testing for medical devices and med tech. She ensures regulatory-aligned study protocols, ethical compliance, and high-quality data generation - significantly reducing translational risk and strengthening investor confidence in the product development pathway.

Prof. Bárbara Loureiro is a globally trained veterinary scientist and translational research expert, bringing deep expertise in animal sciences and preclinical validation of medical technologies. She serves as Assistant Professor of Veterinary Medicine at the University of Vila Velha (Brazil) and Clinical Associate Professor at Iowa State University (USA), combining academic leadership with hands-on clinical and research experience.

With a PhD in Animal Molecular and Cellular Biology from the University of Florida (Fulbright alumna), Prof. Loureiro specializes in bridging laboratory research and real-world biological application — a critical component in the development and regulatory pathway of innovative medical devices.

She has authored 25 peer-reviewed international publications and over 50 scientific abstracts and serves as a scientific reviewer for high-impact journals including Theriogenology, Scientific Reports, and Animal Reproduction Science. Her role as an Ad Hoc Consultant for the São Paulo Research Foundation further demonstrates her expertise in evaluating scientific rigor and innovation.

Portrait of Mr. Richard Baker.

Intellectual Property Strategy & Monetization

Mr. Richard Baker

Senior Intellectual Property executive with deep expertise in patent strategy, valuation, licensing, and monetization.

Role in the Company

Oversees IP valuation, royalty strategy, and licensing negotiations. Develops and manages patent portfolio expansion, monetization pathways, and litigation positioning — ensuring protection of core technology and maximizing long-term asset value.

  • Former Director of IP Licensing at 3Com Corporation (portfolio of 1,400+ U.S. patents; led licensing strategy prior to HP acquisition)
  • Former Director of Intellectual Property, Schneider Automation – built and structured full corporate IP program
  • Expertise in patent portfolio development, royalty structuring, and high-value licensing negotiations
  • Advanced studies in Intellectual Property (Franklin Pierce Law Center) and Applied Mathematics/Computer Science (Harvard University)

Led large-scale patent licensing programs, structured monetization strategies, managed IP sales processes, and prepared expert royalty valuation reports.

Strengthens investor confidence through defensible IP strategy and scalable licensing models.

Portrait of Mr. Gerardo Cedeno.

Head of Engineering & Systems Integration

Mr. Gerardo Cedeno

MSc, PE

Role in the Company

Mr. Cedeno leads conceptual engineering design, structural validation, and finite element analysis (FEM) for our medical devices innovations. He ensures technical feasibility, mechanical reliability, and optimized performance while conducting laboratory testing and verification.

Mr. Cedeno is a multidisciplinary engineering leader with extensive expertise in structural analysis, product architecture, and systems integration for advanced technology projects. His background in both mechanical and electrical engineering enables a comprehensive approach to transforming innovative concepts into robust, scalable medical device products.

He holds three advanced engineering degrees:

  • MSc in Production Management, TUHH (Germany) — product development, robotics, biomechanics, and advanced production systems;
  • MSc in Mechanical Engineering, Lund University (Sweden) — manufacturing systems and thermodynamics;
  • Engineer’s Degree in Mechanical Engineering, Simón Bolívar University — mechanical design, structural analysis, dynamics, materials science, and fluid mechanics.

His work included product planning, concept development, CAD modeling, FEM analysis, topology optimization, 3D printing, laboratory testing, and preparation for manufacturing — demonstrating full-cycle product development capabilities from concept validation to production readiness.

His experience in engineering and advanced product development significantly reduces technical risk, strengthens product scalability, and accelerates time-to-market — critical drivers of investor confidence and long-term commercial success.

Portrait of Mr. Spetetchii.

Head of Prototyping & Product Realization

Mr. Spetetchii

Role in the Company

Leads the Prototypes Department, overseeing the fabrication, optimization, and testing of functional prototypes for product validation.

  • Advanced expertise in CAD/CAM and virtual simulation
  • Certified SolidWorks Professional (Mechanical Design)
  • Rapid prototyping and mechanical component optimization
  • Simulation-driven validation prior to physical manufacturing

Mr. Spetetchii specializes in transforming engineering concepts into manufacturable, test-ready prototypes. He integrates mechanical design, virtual simulation, and precision fabrication to accelerate product iteration cycles and reduce development risk.

Previously led high-level academic engineering.

Get in touch

Meddent Innovative Concepts LLC

5353 Reyes Adobe Rd.
Agoura Hills, CA, USA 91301

Ph. 833 878 2846

Exterior of the Meddent Innovative Concepts office building in Agoura Hills, California.
5353 REYES ADOBE RD · AGOURA HILLS, CA
Vision

To become a leading global innovation platform for orthopedic, dental, and veterinary medical technologies, improving patient outcomes while creating substantial value for healthcare providers, strategic partners, and investors.